1. Epigenetic inhibitors eliminate senescent melanoma BRAFV600E cells that survive long‑term BRAF inhibition
   Florencia Madorsky Rowdo et al, 2020, International Journal of Oncology CrossRef
2. Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance
   Martina Radić et al, 2022, International Journal of Molecular Sciences CrossRef
3. High expression of MLANA in the plasma of patients with head and neck squamous cell carcinoma as a predictor of tumor progression
   Dorival Mendes Rodrigues‐Junior et al, 2019, Head & Neck CrossRef
4. The Cross Talk between Cellular Senescence and Melanoma: From Molecular Pathogenesis to Target Therapies
   Jiahua Liu et al, 2023, Cancers CrossRef
5. A Nonquiescent “Idling” Population State in Drug-Treated, BRAF-Mutated Melanoma
   B. Bishal Paudel et al, 2018, Biophysical Journal CrossRef